ALLIANCEBERNSTEIN L.P. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$2,858,519
+119.3%
74,460
+8.4%
0.00%0.0%
Q2 2023$1,303,239
+46.6%
68,700
+19.9%
0.00%
Q1 2023$888,723
-38.0%
57,300
-29.0%
0.00%
-100.0%
Q4 2022$1,432,425
+198.4%
80,700
-6.2%
0.00%
Q3 2022$480,000
+47.2%
86,000
+2.9%
0.00%
Q2 2022$326,000
-26.1%
83,600
+4.4%
0.00%
Q1 2022$441,000
-35.2%
80,100
+0.3%
0.00%
Q4 2021$681,000
-7.2%
79,900
-5.4%
0.00%
Q3 2021$734,000
-24.9%
84,500
-8.6%
0.00%
Q2 2021$978,000
+82.1%
92,500
+176.1%
0.00%
Q1 2021$537,000
-85.0%
33,500
-56.7%
0.00%
-100.0%
Q4 2020$3,577,000
-42.1%
77,437
-55.9%
0.00%
-33.3%
Q3 2020$6,173,000
+133.3%
175,415
+61.4%
0.00%
+50.0%
Q2 2020$2,646,000
+208.4%
108,659
+97.0%
0.00%
+100.0%
Q1 2020$858,00055,1540.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2020
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders